These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 16133712

  • 1. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
    Matsumura T, Fujii T, Miura T, Koibuchi T, Endo T, Nakamura H, Odawara T, Iwamoto A, Nakamura T.
    J Infect Chemother; 2005 Aug; 11(4):196-8. PubMed ID: 16133712
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
    Mizuno Y, Kudo K, Kano S.
    Southeast Asian J Trop Med Public Health; 2006 Aug; 37 Suppl 3():11-4. PubMed ID: 17547042
    [Abstract] [Full Text] [Related]

  • 4. Controversies and misconceptions in malaria chemoprophylaxis for travelers.
    Chen LH, Wilson ME, Schlagenhauf P.
    JAMA; 2007 May 23; 297(20):2251-63. PubMed ID: 17519415
    [Abstract] [Full Text] [Related]

  • 5. Mefloquine to prevent malaria: a systematic review of trials.
    Croft A, Garner P.
    BMJ; 1997 Nov 29; 315(7120):1412-6. PubMed ID: 9418088
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mefloquine for malaria chemoprophylaxis 1992-1998: a review.
    Schlagenhauf P.
    J Travel Med; 1999 Jun 29; 6(2):122-33. PubMed ID: 10381965
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor.
    Fujii T, Kaku K, Jelinek T, Kimura M.
    J Travel Med; 2007 Jun 29; 14(4):226-32. PubMed ID: 17617844
    [Abstract] [Full Text] [Related]

  • 11. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team.
    Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
    Hoebe C, de Munter J, Thijs C.
    Eur J Clin Pharmacol; 1997 Oct 01; 52(4):269-75. PubMed ID: 9248763
    [Abstract] [Full Text] [Related]

  • 13. Malaria prevention and stand-by emergency treatment among Japanese travelers.
    Kimura M, Kawakami K, Hashimoto M, Hamada M.
    Travel Med Infect Dis; 2006 Mar 01; 4(2):81-5. PubMed ID: 16887729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Update on prevention of malaria for travelers.
    Lobel HO, Kozarsky PE.
    JAMA; 1997 Dec 03; 278(21):1767-71. PubMed ID: 9388154
    [Abstract] [Full Text] [Related]

  • 16. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B, Peguet C, Nevez G.
    Trop Med Int Health; 1997 Oct 03; 2(10):953-6. PubMed ID: 9357484
    [Abstract] [Full Text] [Related]

  • 17. Malaria in long-term travelers: Infection risks and adherence to preventive measures - A prospective cohort study.
    Suryapranata FST, Overbosch FW, Matser A, Grobusch MP, McCall MBB, van Rijckevorsel GGC, Prins M, Sonder GJB.
    Travel Med Infect Dis; 2022 Oct 03; 49():102406. PubMed ID: 35934313
    [Abstract] [Full Text] [Related]

  • 18. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S, Nieforth K, Smith P, Schlagenhauf P, Adamcova M, Tatt I, Tomianovic D, Schnetzler G.
    Travel Med Infect Dis; 2014 Oct 03; 12(6 Pt B):726-32. PubMed ID: 25443997
    [Abstract] [Full Text] [Related]

  • 19. The position of mefloquine as a 21st century malaria chemoprophylaxis.
    Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG.
    Malar J; 2010 Dec 09; 9():357. PubMed ID: 21143906
    [Abstract] [Full Text] [Related]

  • 20. Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
    Adamcova M, Schaerer MT, Bercaru I, Cockburn I, Rhein HG, Schlagenhauf P.
    Travel Med Infect Dis; 2015 Dec 09; 13(5):400-8. PubMed ID: 26119539
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.